Glycogenic Hepatopathy: Thinking Outside the Box.
Glycogenic hepatopathy (GH) remains underrecognized in adults as most clinicians mistake it for the more common hepatic abnormality associated with uncontrolled diabetes mellitus in this age group, non-alcoholic fatty liver disease. This is also complicated by the fact that both entities are indistinguishable on liver ultrasound. We herein describe a similar predicament in which a young adult female presented with bilateral upper quadrant abdominal pain, tender hepatomegaly, lactic acidosis and a >10-fold increase in liver enzymes, which worsened after the administration of high-dose steroids. Despite intravenous normal saline resuscitation, serum transaminitis persisted in a fluctuating manner. Ultimately, a liver biopsy confirmed GH. Biochemically, GH is driven by high amounts of both circulating glucose and insulin or by the administration of high-dose steroids. Improving glycemic control is the mainstay of treatment for GH. However, in our case, improvement in glycated hemoglobin of just 0.6% was enough to achieve symptomatic relief, supporting recent claims of the involvement of other identified factors in disease development.
Department of Internal Medicine, Sanford USD School of Medicine, Sioux Falls, S. Dak., USA.
Nishant
N
Parmar
Sanford Center for Digestive Health, Sanford USD Medical Center, Sioux Falls, S. Dak., USA.
Muslim
M
Atiq
Sanford Center for Digestive Health, Sanford USD Medical Center, Sioux Falls, S. Dak., USA.
Lee
L
Austin
Department of Pathology, The Methodist Hospital, Houston, Tex., USA.
Ross A
RA
Miller
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn., USA.
Thomas
T
Smyrk
Department of Internal Medicine, Sanford USD School of Medicine, Sioux Falls, S. Dak., USA.
Kabir
K
Ahmed
Celiac disease; Dual-echo magnetic resonance imaging; Elevated liver enzymes; Glycogenic hepatopathy; Hepatomegaly; Non-alcoholic fatty liver disease